Chinook Therapeutics Report issue

For profit Phase 1 Phase 3
Founded: Vancouver Canada (2019)
Status: Acquired by Novartis (2023)

Organization Overview

First Clinical Trial
2020
NCT04684745
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chinook Therapeutics | Chinook Therapeutics, Inc. | Chinook Therapeutics U.S., Inc.